[March 22, 2013]

Research and Markets: Denmark In Vitro Diagnostics Market Outlook to 2017

Research and Markets (http://www.researchandmarkets.com/research/36s67b/denmark_in_vitro) has announced the addition of the "Denmark In Vitro Diagnostics Market Outlook to 2017- Clinical Chemistry Genetic Testing, Haematology, Histology and Cytology, Immuno Chemistry, Infectious Immunology and Microbiology Culture" report to their offering.

GlobalData's new report, Denmark In Vitro Diagnostics Market Outlook to 2017- Clinical Chemistry Genetic Testing, Haematology, Histology and Cytology, Immuno Chemistry, Infectious Immunology and Microbiology Culture provides key market data on the Denmark In Vitro Diagnostics market.

The report provides value (USD million) for each segment and sub-segment within seven market categories - Clinical Chemistry, Genetic Testing, Haematology, Histology And Cytology, Immuno Chemistry, Infectious Imunology and Microbiology Culture.

The report also provides company shares and distribution shares data for each of the aforementioned market categories. The report is supplemented with global corporate-level profiles of the key market participants with information on company financials and pipeline products, wherever available.

Scope

- Market size and company share data for In Vitro Diagnostics market categories - Clinical Chemistry, Genetic Testing, Haematology, Histology And Cytology, Immuno Chemistry, Infectious Immunology and Microbiology Culture.

- Annualized market revenues (USD million) data for each of the segments and sub-segments within seven market categories. Data from 2003 to 2010, forecast forward for 7 years to 2017.

- 2010 company shares and distribution shares data for each of the seven market categories.

- Global corporate-level profiles of key companies operating within the Denmark In Vitro Diagnosticsmarket.

- Key players covered include F. Hoffmann-La Roche Ltd., Siemens (News - Alert) Healthcare, Abbott Laboratories, Ortho-Clinical Diagnostics Inc., Beckman Coulter, Inc., bioMerieux S.A. and others.

Reasons to buy

- Develop business strategies by identifying the key market categories and segments poised for strong growth.

- Develop market-entry and market expansion strategies.

- Design competition strategies by identifying who-stands-where in the Denmark In Vitro Diagnostics competitive landscape.

- Develop capital investment strategies by identifying the key market segments expected to register strong growth in the near future.

- What are the key distribution channels and what's the most preferred mode of product distribution - Identify, understand and capitalize.

For more information visit http://www.researchandmarkets.com/research/36s67b/denmark_in_vitro

[ Back To Technology News's Homepage ]